Adaptive Immunity Regulation and Cerebral Ischemia

Area of Science:

• Neuroimmunology
• Cerebrovascular Disease
• Inflammation

Background:

• Stroke, a leading cause of death and disability, involves immune system-driven brain injury.
• Both innate and adaptive immune systems play critical, synergistic roles in ischemic stroke.
• Inflammation and blood-brain barrier (BBB) compromise are key features following ischemic events.

Purpose of the Study:

• To review the key components of the adaptive immune system activated post-cerebral ischemia.
• To elucidate the dual role of the adaptive immune system in stroke: immunodepression and autoimmunity prevention.

Main Methods:

• Review of scientific literature on immune responses following ischemic stroke.
• Analysis of the roles of T cells and B cells in modulating inflammation and immune suppression.
• Examination of damage-associated molecular patterns (DAMPs) and their activation of the innate immune system.

Main Results:

• The innate immune system is activated by DAMPs, increasing inflammation and BBB damage.
• Within 24 hours, the adaptive immune system (T cells, B cells) becomes active, releasing cytokines.
• The adaptive immune system can lead to post-stroke immunodepression, increasing infection risk, but also prevents autoimmunity.

Conclusions:

• The adaptive immune system plays a complex role in the aftermath of ischemic stroke.
• Understanding these adaptive immune responses is crucial for developing novel stroke therapies.
• Further research into modulating adaptive immunity could mitigate stroke-induced brain injury and complications.